- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04279665
Virtual Reality to Reduce Intra-procedural Anxiety and Sedation Needs During Procedures
March 15, 2021 updated by: Suraj Kapa, Mayo Clinic
Use of Virtual Reality to Reduce Intra-procedural Anxiety and Sedation Needs During Procedures Involving no or Minimal Sedation
Researchers are assessing whether use of a virtual reality experience, used during the procedure, can reduce anxiety and improve satisfaction related to the procedure, especially when no or little sedation is being used.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing invasive EP procedures with plan for no or minimal conscious sedation
Exclusion Criteria:
- Patients unable to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Subjects undergoing electrophysiology procedure
Subjects will wear a virtual reality (VR) headset for a total of 40 minutes separated over 2 sessions during an electrophysiology procedure they are already scheduled to undergo.
|
20 minutes of wearing a virtual reality headset with a choice of 4 environments based on their preference and another 20 minutes with a less immersive condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject anxiety
Time Frame: 20 minutes
|
Measured using a survey question asking participants to rank their anxiety level over the last 20 minutes using a scale of 5 being extremely good (ie, less anxiety); 1 being extremely bad (ie, more anxiety).
|
20 minutes
|
|
Subject comfort
Time Frame: 20 minutes
|
Measured using a survey question asking participants to rank their comfort over the last 20 minutes using a scale of 5 being extremely positive; 4 being somewhat positive; 3 being neutral; 2 being somewhat negative; 1 being extremely negative
|
20 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Suraj Kapa, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 20, 2020
Primary Completion (ACTUAL)
December 1, 2020
Study Completion (ANTICIPATED)
January 1, 2021
Study Registration Dates
First Submitted
February 19, 2020
First Submitted That Met QC Criteria
February 19, 2020
First Posted (ACTUAL)
February 21, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 17, 2021
Last Update Submitted That Met QC Criteria
March 15, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-005788
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmia
-
Medical University of LodzNot yet recruitingCardiac Arrhythmia | Supraventricular ArrhythmiaPoland
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
Fayoum University HospitalRecruiting
-
Boston Scientific CorporationNot yet recruitingAtrial Arrhythmia | Intracardiac EchocardiographyNew Zealand, Malaysia, Greece, Croatia, Singapore, Poland, Czechia, Australia
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Arrhythmia | Heart Failure, Congestive | Sinus Arrhythmia
-
Ceryx Medical AustraliaAvaniaRecruitingHeart Failure With Reduced Ejection FractionAustralia, New Zealand
-
Ceryx Medical LtdCardiff and Vale University Health BoardRecruitingHeart Failure With Reduced Ejection FractionUnited Kingdom
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationRecruiting
-
University of UtahAltaThera Pharmaceuticals, LLCCompleted
-
Universitätsklinikum KölnUnknown
Clinical Trials on Virtual Reality (VR)
-
National Institute of Mental Health, Czech RepublicCharles University, Czech Republic; Motol University HospitalCompletedLife Threatening Diseases | Pediatric Palliative Care | Life Limiting ConditionsCzechia
-
Filiz KeskinEnrolling by invitationPregnancy | Sleep Quality | Comfort | Nausea and Vomiting in Pregnancy (NVP)Turkey (Türkiye)
-
University Health Network, TorontoMichael Garron Hospital; Centre for Aging and Brain Health InnovationTerminatedDementia | Delirium Superimposed on DementiaCanada
-
University of MiamiEnrolling by invitation
-
University of California, Los AngelesCompleted
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of California, Los AngelesRecruiting
-
Sultan Qaboos UniversityNot yet recruitingStroke Patients
-
Eastern Mediterranean UniversityCompleted
-
Abby GeerlingsCompletedAnxiety | Mitral Regurgitation | Virtual Reality | Mitraclip | Tricuspid Regurgitation (TR) | TriClipNetherlands